Abstract
The expectation of life has risen constantly in most of the industrialized countries in the last 80 years. It was shown that the over 65 year-old US-population has grown from 3 millions in 1900 to more than 27 millions in 1984. About 6% of these persons suffered from Alzheimer’s disease. This group of illnesses increases with age — about 20–25% of people aged 85 years will be affected — actually more than 2 millions; in 65 years time this number will have increased to 16 million persons (G.D. Cohen 1986). B.E. Tomlinson (1986) pointed out that a world-wide collaboration and the search of subgroups with detailed analysis of cases — early onset or late onset — is required. Among the multiple aetiological factors, dementia caused by ischaemic lesions must be separated from dementias of other origin. “Our thinking about Alzheimer’s disease is too restricted if we assume that chemical and neuropathological findings and aetiology have to be identical and consistent from case to case” (Tomlinson). Davison (1982) pointed out that “functional deficits are greater than they would be expected from the neuropathological changes”.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Amaducci, L., Schoenberg, B.S.: Analytic Epidemiology and Risk Factors in Alzheimer’s disease. In: Neurology, Proceed. XIIIth World Congress Neurol. K. Poeck, H.J. Freund and H. Gänshirt, p. 85–91. Springer-Verlag, BerlinHeidelberg-New York-Tokyo 1986.
Bagne, C.A., Pomara, N., Crook, T., Gershon, S.: Alzheimer’ s Disease: Strategies for treatment and research. In: Treatment development strategies for Alzheimer’s Disease, T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 585–636. MarkPawley Ass, Madison, Conn. 1986.
Banks, W.A., Kastin, A.J.: Aging, peptides and the blood-brain barrier: Implications and spectulations. In: Treatment development strategies for Alzheimer’s Disease, T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 245–266. Mark Pawley Ass, Madison, Conn. 1986.
Bloom, F.E.: Molecular diversity and neuronal function. In: Molecular aspects of neurobiology, R.L. Montalcene, P. Calissano, E.R. Kandel, A. Maggi, p. 188–192. Springer-Verlag, Berlin-Heidelberg-NewYork-Tokyo 1986.
Bowen, D.M., and Davison, A.N.: Can the Pathophysiology of Dementia Lead to Rational Therapy? In: Treatment Development Strategies for Alzheimer’s Disease, T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 34–66. Mark Pawley Ass, Madison, Conn., 1986.
Calderini, G., Bonetti AC, Battistella A. et al.: Biochemical Changes of Rat Brain Membranes with Aging. Neurochernical Res. 18: 483–92 (1983).
Cohen, G.D.: Foreword. In: Treatment Development Strategies for Alzheimer’s Disease, T. Crook, R. Bartus, S. Ferris, S. Gershon. Mark Pawley Ass, Madison, Conn., 1986.
Constantinidis, J.: Genetics of Vascular and Degenerative Dementias: The Geneva Studies. In: Modem Approaches to the Dementias, ed. F.C. Rose–Interdiscipl. Topics Geront., vol. 19, pp. 1–11, KArger, Basel 1985.
Davison, A.N.: Dementia. In: Disorders of Neurohumoral Transmission, ed. T.J. Crow, p. 341–369. London, New York etc. Academic Press 1982.
Fünfgeld, E.W.: Neue therapeutische Möglichkeiten für Parkinson-Patienten. Praxis-Kurier 25, Nr. 37, 25–28 (1987).
Fünfgeld, E.W.: Editorial: Multitherapie der Parkinson-Krankheit und der senilen Demenz vom Alzheimer Typ. Therapiewoche 37, 4521–4522 (1987).
Fünfgeld, E.W., Stalleicken, D.: Dynamic-Brain-Map**. TW Neurol.Psychiatr. 2, 136–142 (1987).
Heiss, W.D., Pawlik, G., Herholz, K., Szelies, B., Beil, C., Wienhard, K.: Investigation of Regional Cerebral Blood Flow and Metabolism in Dementia. In: Senile Dementia of the Alzheimer Type, J. Traber and W.H. Gispen, p. 134–147. Springer-Verlag, Berlin-Heidelberg-New York-Tokyo 1985.
Hershkowitz, M.: Mechanisms of Brain Ageing - The Role of Membrane Fluidity. In: Aging of the Brain, W.H. Gispen and J. Traber, p. 85–99. Elsevier, Amsterdam-New York-Oxford 1983.
Hoyer, S.: Circulation and Oxidative Metabolism in the Normally and Abnormally Aging Brain. In: Aging of the Brain, W.H. Gispen and J. Traber, p. 151–165. Elsevier, Amsterdam-New York-Oxford 1983.
Itil, T.M., Shapiro, D.M., Eralp, E., Akman, A., Itil, K.Z., Garbizu, C.: A new Brain Function Diagnostic Unit, Including the Dynamic Brain Map** of Computer Analyzed EEG, Evoked Potentials and Sleep (a new Hardware/Soft-ware System and its Application in Psychiatry and Psychopharmacology). New trends in exp. and clin. psychiat. 1,107–177 (1985) — Basic Publication —.
Krüger, G., Haubitz, I. and Hoyer, S.: Organic Psychiatric Disease in Young Adults and Aged Patients. In: The Aging Brain — Exper. Brain Research Supp. 5, ed. S. Hover, p. 236–242. Springer-Verlag, Berlin-Heidelberg-New York 1982.
Montarolo, P., Schacher, S., Castelucci, V.F., Hawkins, R.D., Abrams, T.W., Goelet, P., Kandel, E.R.: Interrelationships of cellular mechanism for different forms of learning and memory. In: Molecular aspects of neurobiology, R.L. Montalcene, P. Calissano, E.R. Kandel, A. Maggi. p. 1–14. Springer-Verlag, Berlin-Heidelberg-New York 1986.
Sapolsky, M., and McEwen, B.S.: Stress, Glucocorticoids, and Their Role in Degenerative Changes in the Aging Hippocampus. In: Treatment Development Strategies for Alzheimer’s Disease,eds. T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 150–171. Mark Pawley Ass, Madison, Conn. 1986.
Sun, A., Sun, G.Y.: Neurochemical Aspects of the Membrane Hypothesis of Aging. In: Interdisciplinary Topics in Gerontology. 15: CNS Aging and Its Neuropharmacology, ed. W. Meier-Ruge, p. 34–53, Karger, Basel 1979.
Tomlinson, B.E.: The Dementias: A view to the future. In: Neurology, Proceed. XIIIth World Congress Neurol. K. Poeck, H.J. Freund and H. Gänshirt, p. 131–137. Springer-Verlag, Berlin-Heidelberg-New York-Tokyo 1986.
Vogt, O., Vogt, C.: Sitz und Wesen der Krankheiten im Lichte der topistischen Hirnforschung und des Variierens der Tiere. J.A. Barth, Leipzig 1937 und 1938.
Whalley, L.J., Wright, A.F., and Clair, D.M. St.: Genetic Factors in Down’s Syndrome and Their Possible Role in the Pathogenesis of Alzheimer’s Disease. In: Modern Approaches to the Dementias, ed. F.C. Rose — Interdiscipl. Topics Geront., vol. 19. pp. 18–31. Karger, Basel 1985.
Whitehouse, P.J., Au, K.S.: Neurotransmitter receptor alterations in Alzheimer’s disease. In: Senile Dementia of the Alzheimer Type, J. Traber, W.H. Gispen, p. 175–182. Springer-Verlag, Berlin-Heidelberg-New York-Tokyo 1985.
Winblad, B.G., Bucht, G., Fowler, C.J., Wallace, W.: Beyond the transmitter-based approach to Alzheimer’s Disease. In: Treatment Development Strategies for Alzheimer’s Disease, eds. T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 67–97. Mark Pawley Ass, Madison, Conn. 1986.
Wisniewski, H., Merz, G.S., and Carp., R.I.: Current Hypothesis of the Etiology and Pathogenesis of Senile Dementia of the Alzheimer Type. In: Modern Approaches to the Dementias, ed. F.C. Rose — Interdiscipl. Topics Geront., vol. 19, pp. 18–31. Karger, Basel 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg New York
About this paper
Cite this paper
Fünfgeld, E.W. (1988). Dementias — A Growing Social and Medical Problem. In: Fünfgeld, E.W. (eds) Rökan. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73686-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-73686-5_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19261-9
Online ISBN: 978-3-642-73686-5
eBook Packages: Springer Book Archive